Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Jounce Therapeutics history
Jounce Therapeutics company history timeline
Robert Kamen, Ph.D., has served as a member of our board of directors since June 2013.
Richard Murray has served as Chief Executive Officer and President of Jounce Therapeutics, along with sitting on the Board of Directors, since July, 2014.
J. Duncan Higgons has served as a director on our board of directors since November 2015.
Barbara Duncan has served as a director on our board of directors since May 2016.
He and his team conceptualized and executed the landmark proof-of-concept study using PD-1 blockade in patients with MSI-H, which led to the historic first pan-tumor FDA approval for any solid tumors with this genetic lesion in May 2017.
Luis A. Diaz, Jr., M.D. has served as a director on our board of directors since October 2017.
Haley Laken, Ph.D. joined Jounce in March 2018 and brings more than 20 years of experience in biotech and pharmaceutical large molecule drug development strategy and execution.
Doctor Iannone currently serves as the executive vice president, research and development of Jazz Pharmaceuticals, which he joined in May 2019.
Robert Iannone, M.D., M.S.C.E. has served as a director on our board of directors since January 2020.
In this role, she led the creation and implementation of clinical development plans for Promedior’s lead macrophage product candidate, PRM-151, which led to the acquisition of Promedior by Roche in 2020.
Luisa Salter-Cid, Ph.D., has served as a director on our board of directors since February 2021.
Rate how well Jounce Therapeutics lives up to its initial vision.
Jounce Therapeutics jobs
Do you work at Jounce Therapeutics?
Does Jounce Therapeutics communicate its history to new hires?
Jounce Therapeutics history FAQs
Zippia gives an in-depth look into the details of Jounce Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Jounce Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Jounce Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Jounce Therapeutics. The data presented on this page does not represent the view of Jounce Therapeutics and its employees or that of Zippia.
Jounce Therapeutics may also be known as or be related to JOUNCE THERAPEUTICS INC., Jounce Therapeutics, Jounce Therapeutics Inc and Jounce Therapeutics, Inc.